Ventyx biosciences to participate in the canaccord genuity 43rd annual growth conference

San diego, aug. 02, 2023 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that company executives will participate in a fireside chat at the canaccord genuity 43rd annual growth conference being held on august 9, 2023.
VTYX Ratings Summary
VTYX Quant Ranking